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Abstract: 
Most of our knowledge of bone cell physiology is derived from experiments carried out in 
vitro on polystyrene substrates. However, these traditional monolayer cell cultures do not 
reproduce the complex and dynamic 3-dimensional (3D) environment experienced by cells in 
vivo. Thus, there is a growing interest in the use of 3D culture systems as tools for 
understanding bone biology. These in vitro engineered systems, less complex than in vivo 
models, should ultimately recapitulate and control the main biophysical, biochemical and 
biomechanical cues that define the in vivo bone environment, while allowing their 
monitoring. This review focuses on state of the art and the current advances in the 
development of 3D culture systems for bone biology research. It describes more specifically 
advantages related to the use of such systems, and details main characteristics and 
challenges associated with its three main components, i.e. scaffold, cells and perfusion 
bioreactor systems. Finally, future challenges for non-invasive imaging technologies are 
addressed. 
 
Keywords: Bone tissue engineering, Perfusion bioreactor, Cell culture, Scaffold, Experimental 
approaches, Mechanical stimuli 
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1. CONTEXT 
1.1. Tissue Engineering: concepts 
Tissue engineering is the application of the principles of biology and engineering to the 
development of artificial living tissues (1). It utilises specific combinations of cells, matrices 
(referred also as “scaffolds or constructs”), as well as cellular, chemical and mechanical 
signals. Generally speaking, current applications of tissue engineering can be divided into 
two categories. 
The first category consists of elaborating biological substitutes to restore, maintain or 
improve tissue functions (1). This therapeutic approach aims to replace/repair damaged 
human tissues with manufactured tissue-engineered products. This field is quickly expanding 
due to coordinated and converging technological developments in the creation and/or 
manipulation of biomolecules, biological materials, cells and tissues, with the goal of 
ultimately generating pseudo-tissues and organs for transplant. Such therapy will be 
drastically different from classical prosthesis implants, avoiding integration, interface and 
wearing-out problems, thus allowing for a longer lived tissue/organ substitution. 
The second category of applications of tissue engineering aims to understand the 
fundamental aspects of cells working in vivo in 3D controlled systems. In fact, in vivo cells 
reside in a complex three dimensional (3D) micro-environment, encompassing several cell 
types producing/exchanging many signals, interacting in a dynamic fashion amongst 
themselves. These cells also interact with an extracellular matrix whose rigidity varies in time 
and space with the nature and/or maturity of the cell type/tissue (2, 3). Moreover, in tissues 
like bone, cells experience various mechanical stresses (e.g. compression forces). Therefore, 
in vitro 3D systems, based on tissue engineering principles, strive to reproduce (at least 
partly) the in vivo environment of cells in a scaffold material. As it was recently 
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demonstrated by many studies (4, 5) for review), such systems implies the use of perfusion 
bioreactors to control and monitor biochemical and mechanical signals throughout cell 
culture.  
Such complex models represent the best approach to understand the bone (cell) biology 
since they allow study of a multicellular microenvironment whose structure, composition, 
topology and perfusion conditions are adaptable and more realistic, respective to the in vivo 
situation, than the current two dimensional (2D) standard cell culture method.  For instance, 
in these systems it will be possible to test the effects of chemical substances or characterise 
stimuli acting locally on cell metabolism in order to understand cellular and matrix changes 
involved in aging mechanisms and some diseases (e.g. osteoporosis); they will also provide 
tools for assessing drugs in development in toxicology or pharmacology studies. 
The knowledge gained from such experiments will advance our understanding of 
pathophysiology as well as the prevention, diagnosis and treatment of diseases. 
 
1.2. From 2D in vitro cell culture to native bone tissue, the missing link 
Bone tissue development and remodeling in living organisms are orchestrated by cascades of 
regulatory factors interacting at multiple levels, in both time and space. 
Animal models provide the full complexity of biological systems (at least within a given 
species), but they offer limited control of the local environment and scanty real time 
information. In contrast, traditional cell culture in 2D allows significant control of the cellular 
environment and a direct access to cellular processes. However, these culture conditions are 
drastically simplified and hardly reproduce the typical bone environment in the 
organ/organism, in which (bone) cells develop in a 3D structure subjected to mechanical 
stimulation. Moreover, it is well established that signal transduction and many other cellular 
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functions differ between 2D and 3D culture conditions (6-8). These differences are expected 
since on 2D substrates the cells have to adapt to an artificial flat and rigid surface.  For 
instance, Elsdale et al have shown that morphological changes in fibroblasts cultivated onto 
2D plastic or in 3D collagen gels are different. More precisely, cells cultivated in 3D gels are 
more similar to connective tissue cells in vivo than on 2D (9). These results highlight the 
relevance of 3D systems to reproduce in vivo environment. 
Cultivating cells in a scaffold provides 3D architecture and potentially mechanical 
stimulation, but it is only the first step towards 3D in vitro models reproducing the in vivo 
environment for long-term studies. Indeed, cells seeded in scaffolds and cultivated under 
static condition (in multiple well plates) tend to reach high concentration at the scaffold 
periphery, resulting in poor nutrient and waste exchange in the middle of the scaffold and 
thus cell necrosis in the center of the scaffold. Perfusion bioreactors were designed to avoid 
this drawback and establish a closely monitored and tightly controlled environment. The 
perfusion also permits to mechanically stimulate the cells via shear stress (10) for review). 
These bioreactors can be improved with the addition of a compression system dissociated 
from or combined with perfusion (11), which is particularly useful and relevant in bone cell 
studies (e.g. analysis of mechanotransduction (12)). 
Three-dimensional artificial models can thus overcome the limitation of current 2D models 
by providing robust spatial and temporal control of biophysical, biochemical and mechanical 
micro-environmental cues (13-15). Additionally, the development of such alternative 
methods follows the ethical regulation drive to reduce the use of animal models. 
 
In this review, we provide an overview of the main concepts, key points and challenges 
about in vitro 3D cultures dedicated to experimental/fundamental research in bone biology. 
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In particular, it focuses on the four main components of such strategy: the scaffold, the cells, 
the bioreactor and the none-invasive imaging technologies.  
 
2. SCAFFOLD 
2.1. Why use scaffolds? 
As mentioned previously, in vitro bone development requires 3D organization to simulate 
the structure, mechanical properties (i.e. stiffness and strength), composition as well as 
regulatory cues of the natural ECM (16, 17). 3D artificial models may provide a robust spatial 
and temporal monitoring of biophysical, biochemical and mechanical micro-environmental 
cues; this monitoring is unavailable in vivo (14). As such, they are crucial tools for identifying 
regulators and pathways of bone cell behavior and fate. 
 
2.2. Ideal scaffold properties 
While the success of an implanted scaffold in vivo will be based on its capacity to be invaded, 
degraded then replaced by host tissue, the purpose of a scaffold for in vitro experimental 
application is to provide a structural support for the culture of cells in a controlled 3D 
environment in vitro. This environment should meet as many as possible of the 
requirements of the cells used, and ideally mimic the dynamic native niche environment of, 
e.g. stem cells (18, 19). Even though there are no unique scaffold specifications for such 
experimental applications, scaffold needs to be at least biocompatible and osteoconductive 
to support cell attachment, growth and differentiation (20). Moreover, although the final 
features depend on the specific purpose of the in vitro study, several general characteristics 
and requirements need to be considered for all designs. Besides stiffness (14, 21), scaffolds 
must have adequate mechanical properties to support, if applicable, flow perfusion and 
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mechanical stimuli (e.g. compressive strength). Scaffolds for in vitro use do not necessarily 
have to be degradable (i.e. soluble and/or resorbable). However, the phase and chemical 
composition, as well as surface chemistry (cell-surface interface), are key parameters that 
affect cellular responses (22, 23). Similarly, architecture influences the interactions between 
the cells, the media and the material, ultimately controlling the rate and quality of new 
tissue formation (e.g. extracellular matrix deposition) (14). Both architecture and 
composition are very important features for this application (24) and are detailed in 
following subsections. 
 
2.3. Architecture: A key role 
For a 3D scaffold-based in vitro culture strategy, the scaffold architecture has to allow 
controlled and homogeneous cell seeding (25), cell response (26), mass transport (27), 
substrate degradation (28), and mechanical properties (29) throughout the experiment. The 
scaffold architecture (e.g. geometry, shape, size; as defined below) influences the cell fate 
both directly (e.g. nutrient accessibility) and indirectly (e.g. adsorption of proteins, local 
shear stresses). Macroscopic and microscopic architectural features are distinct (Fig. 1). They 
are generally defined as pore sizes greater than 100 µm and below 20 µm, respectively (for 
review (30)). Numerous studies have investigated the influence of macro- and micro-
architecture on cell response and fate, and both were proved to be of great importance (14). 
Macro-scale architecture can be split into macroscopic design (geometric structure) and 
internal pore structure/architecture, including the shape, size, distribution and 
interconnection of the macropores. Similarly, the micro-scale architecture consists in the 
shape (i.e. morphology), size (width and length), orientation (according to the way of 
perfusion flow for instance) and distribution (ordered vs random) of the micropores. 
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Since the 1990s, studies have emphasized the crucial effects of the micro-scale architecture 
of the constructs on cell seeding and response (26, 31, for review (32)). Micro-architecture 
has been shown to improve scaffold osteoconductivity (33, 34) and cause intrinsic 
osteoinductive activity (35, 36). These modification may be explained by (i) selective 
adsorption of proteins from biological fluids (37, 38), (ii) increase in specific surface area, 
promoting dynamic exchange at the biomaterial-matrix-cell interface (39), or (iii) the 
responsiveness of cells to substrate discontinuities  (40, 41). For a comprehensive review 
focused on calcium phosphate ceramics, see (23). 
According to the literature, the macro-scale architecture influences internal mass-transports 
(e.g. supply of nutrients, removal of deleterious waste compounds) (42), cell 
invasion/infiltration (e.g. seeding) (25, 43), tissue ingrowth (e.g. bone, blood-vessel) (44, 45), 
scaffold degradation (46, 47), inflammatory response (48), shear stress distribution (49, 50), 
and extensive mechanical properties of the scaffold (e.g. stiffness, compressive strength) 
(51). Likewise, the mechanical properties of the scaffold affect the intrinsic mechanical 
stimuli developed at the macroscopic (51) and microscopic cell level (49, 52) which, in turn, 
modify cellular response (20, 27, 53). 
Macropore size has been shown to influence bone cell response in vitro and in vivo (54, 55). 
However, from the literature its effects appear similar for sizes ranging from 100 to 1200 µm 
(56, 57). The reason for this lack of logic are most likely the pore size (and shape) uncertainty 
due to the random internal pore architecture/morphology of the scaffolds used, and the 
method used to assess macropore and interconnection size (and shape) (58). This indicates 
that most studies do not exert sufficient control of the macroporous architecture to ensure 
cell response homogeneity (i.e. cell response related to perfectly defined architectural 
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features), As a consequence, the “mean macropore size” (i.e. macropores and 
interconnections) remains a confounding variable (59), even though it appears as the main 
macroscopic determinant of the biophysical properties of scaffolds (25, 26). 
Advancements in engineering and materials has allowed for subtle tuning of scaffold 
features (e.g. macro-, micro-topography and surface chemistry). These improvements 
provided the opportunity to more accurately control the biophysical and biochemical micro-
environmental cues in 3D biomaterial-based culture systems (13, 60). Many engineering 
methods are used to design and produce 3D scaffolds for tissue engineering applications, 
including porogen leaching (61), phase separation (61), gas foaming (26), replication of 
polymer template (62, 63), bone machining (64), and others (65, 66). Even though the 
internal scaffold architectures produced from these conventional methods can be modified 
by changing the fabrication parameters (synthetic materials), or can provide anatomical 
features with macro- and micro-environmental cues (natural based materials) (24), they 
suffer from sample-to-sample variations (e.g. random pore distribution and size) and design 
limitations. Unfortunately, the limits of these conventional methods prevent the structure 
standardization, as well as the experiment reproducibility; so many detrimental points for 
the creation of in vitro physiological models. Indeed, biological observations (67), physical 
(68) and mechanical (69) features, or simulation based on reconstructed images (70, 71) are, 
in that case, valid for one scaffold but not one architecture, diminishing the predictability of 
results. However, new engineering developments combining computational methods, such 
as computer-aided design (CAD), and additive manufacturing technologies (AM) (72) are able 
to overcome these production limitation by providing higher level of control over the design 
of manufactured scaffolds, with customized external shapes as well as optimized and 
reproducible internal morphologies (e.g. pore interconnectivity, shape, size and distribution) 
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(25, 73, 74). Recent reviews provide exhaustive classification of the different AM techniques, 
design methodologies and their limitations for production of scaffold made of different 
materials (60, 75, 76). Additionally, Giannitelli et al. reviewed studies relating the influence 
of some intrinsic architectural features of scaffold (e.g. porous design, pore morphology), 
controlled by AM fabrication parameters, on their extrinsic properties (e.g. shear stress level 
and distribution, mass transport, biological behavior) related for instance to the selected cell 
type grown or the fluid flow perfusion characteristics (75). A conclusion is that a design 
strategy is needed to match the micro and macro-scale intrinsic architectural features of the 
scaffold to the conflicting mechanical, mass transfer and biological requirements that it has 
to fulfil in a given experimental setup. One way to achieve scaffolds with specific target 
properties is to use computational tools/models to design their structure and AM process for 
their production (75). This strategy has been used to optimize scaffold design for mass 
transport (77), mechanical load (78, 79), or both (80, 81), shear stress at the surface of the 
pore walls (49, 50) and scaffold degradation (21). 
Nevertheless, standard empirical approaches are not obsolete, quite the contrary! Recently, 
Bidan et al. proposed an elegant simple geometric model explaining the shape-dependence 
of growth in terms of tension and local curvature from static in vitro cell culture experiments 
and AM HA ceramics (82). In addition to confirm the model in a second article, they cleverly 
demonstrated that tissue growth into a porous scaffold is a function of pore geometry, 
specifically the local surface curvature (83); for other trial-and-error assessments on the 
influence of macroporosity, see (84, 85). 
Also, beyond the control of the initial scaffold properties, especially permeability and 
mechanical strength, it is also important to anticipate their evolution during in vitro 
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experiments since scaffold degradation processes (e.g. dissolution, resorption, cracks) as 
well as neo-tissue ingrowth can significantly affect them (28). 
Finally, the current limitations of the manufacturing processes result in geometrical 
discrepancies, generally anisotropic, between the fabricated and the designed scaffold (77, 
81). In order to evaluate qualitatively how the fabricated scaffold matches the designed 
structure, scaffolds should be analyzed by high resolution imaging techniques such as micro-
computed tomography (µCT, see section 5). Quantitatively, the high resolution µCT data 
should be used as input in the simulation in order to determine how these differences of 
geometry will influence the final scaffold properties (e.g. permeability) (86).  
 
2.4. Scaffold composition 
Material composition encompasses phase composition (i.e. amorphous or crystalline) and 
chemical composition (i.e. arrangement, type and ratio of atoms in material). Both 
associated to the chemical, mechanical and/or thermal treatments experienced by material 
during the manufacturing process govern the intrinsic chemical (e.g. thermodynamical 
solubility, hydrolysis susceptibility, chemical surface functional groups), physical (e.g. 
crystalline structure, wettability, surface charge), mechanical (e.g. stiffness, mechanical 
strength) and biological (e.g. toxicity, cell attachment) properties of scaffold. These intrinsic 
properties affect in turn the key early event of protein adsorption and subsequent cell 
adhesion, growth, differentiation, matrix deposition and function. Indeed, besides 
microarchitectural features such as roughness (see previous section), the type, conformation 
and density of adsorbed proteins depend mainly on the surface chemical functional groups, 
and on the ionic environment and pH value of the culture medium (for review (23, 86)). The 
latter can be significantly affected by the degradation mechanisms of the material. In vitro, 
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scaffolds can degrade via solution-mediated mechanisms (e.g. dissolution, hydrolysis), cell-
mediated mechanisms (e.g. resorption, phagocytosis), as well as the loss of mechanical 
integrity (e.g. surface cracking) (87, 88). As degradation products can affect cell fate, they 
must also exhibit biocompatibility. 
From a thermodynamic standpoint most calcium phosphates ceramics are faintly soluble in 
aqueous media, since their solubility products are low (89). However, John et al. emphasized 
a clear difference in MG-63 osteoblast-like cells attachment, spreading and growth between 
the quite insoluble hydroxyapatite (HA) and the more soluble β tricalcium phosphate (β TCP) 
ceramics, the former promoting cell adhesion and spreading and not the latter (90). These 
authors attributed the death of cell on β TCP ceramics to the high phosphate and low Ca 
levels in the material/media interface, resulting from dissolution/reprecipitation mechanism. 
An equivalent conclusion was reached by Detsch et al. to explain the inhibition of 
osteoclastic resorption (human monocyte-like cell line U-937) on highly soluble β TCP 
surface (91). Strangely, HA exhibits, as β TCP, negligible degree of resorption as well as low 
rate of bone ingrowth, despite its limited solubility compare to β TCP (91, 92). Thus, even if 
the degradation products of calcium phosphate bioceramics (calcium and phosphate ions) 
are naturally metabolized (93), their concentrations affect cells fate directly (e.g. cell death) 
and indirectly (e.g. proteins adsorption). These observations highlight that cell responses are 
very sensitive to the environment, and indicate that the performance of HA and TCP phases 
are not optimal. A relevant way to modulate/adjust the intrinsic properties of calcium 
phosphate (CaP) bioceramics, including solubility, and in turn the biological response 
consists of a partial replacement of the original constituting ions of the CaP lattice. For 
instance, the beneficial effects of carbonate ion substitution for phosphate and/or hydroxide 
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ions in HA lattice are widely established (92, for review (94)). Thus, managing carbonate 
content permits control of the rate of resorption and dissolution of synthetic carbonated 
hydroxyapatite (CHA) ceramics, which in turn enhance their bioactivity when compared to 
HA. 
Biodegradation of synthetic polymers releases a mixture of oligomers, monomers and other 
low-molecular products. The rate of degradation is governed by intrinsic properties of the 
polymer such as molecular weight, chemical structure, copolymer ratio, crystallinity and the 
proportion of unstable bonds (for review (95)). The degradation products can include 
harmful or acidic byproducts (e.g. PLA, PGA, puramatrix hydrogel) which are harmful to cell 
function/survival (95, 96). In parallel, other physical and chemical surface properties of 
biodegradable polymers appear to be detrimental for tissue formation such as hydrophobic 
surfaces (97) or low cell adhesion capacity (98). 
Cell fate is also driven by the mechanical properties of the scaffold and more particularly its 
stiffness. As in native tissue, cells within a construct respond and adapt to the mechanical 
and biological stimuli to which they are exposed (18, 99). It has been demonstrated by 
Engler et al., on polyacrylamide gels, that the substrate-level elasticity can specify the 
lineage specification of Mesenchymal Stem Cells (MSC, see section 3.1) (100). These results 
were confirmed recently by Zouani et al. (101); see also for review about effect of substrate 
rigidity on stem cells (102). Thus, scaffold used as hard tissue device, like bone, should 
exhibit high elastic modulus (103). Consequently, CaP ceramics, which have a stiffness 
similar to bone (23), have long been used for bone tissue engineering applications. In 
addition to considerable stiffness, CaP ceramics show biocompatibility, tunable bioactivity 
and biodegradability (94), and generally more bioactivity than synthetic polymers (104, 105). 
Yet, the brittle nature of these ceramics is a major issue especially for the application of 
 14
mechanical loading in a bioreactor (see section 4). However, this mechanical deficiency 
could be partly compensated by phase composition adjustment (85) and “topological 
optimization” (see section 2.3). 
The alternatives to inorganic materials for the composition of scaffolds are mainly synthetic 
organic polymers, as naturally derived polymers suffer high batch-to-batch variability (95). 
The main advantage of polymers over ceramic, is that scaffolds can be easily produce with 
tunable micro- and macroscale features. Unfortunately, most porous polymeric scaffolds 
lack sufficient mechanical strength to withstand mechanical loading (for review (106)).  
Combination of inorganic and organic components in a composite biomaterial could 
overcome their respective limitations, but it would make it extremely difficult to relate the 
scaffold physico-chemical properties to biological responses within the 3D model. Other 
materials such as metals (for review (107)) or carbon nanotubes (for review (108)) can 
display interesting properties for the development of 3D artificial models, provided that 
their toxicity and interaction with the biological in vitro environment (e.g. cells, proteins) can 
be controlled. 
The development of 3D in vitro models requires to know the influence of scaffold chemistry 
(e.g. composition, surface chemistry) on cell behavior, and reciprocally to anticipate the 
influence of culture medium chemistry and cell activity on the scaffold. Thus, an ill-defined 
scaffold (i.e. not accurately characterized) will never permit understanding and control in 
reproducible manner the interaction between cells and substrate through adsorbed proteins 
(98). Therefore, batch-to-batch reproducibility of scaffold chemistry is essential to establish 
correlation between scaffold features and cell responses. Our experience on in vitro 3D bone 
model shows that a basic CaP ceramic scaffold with optimized architecture can achieve the 
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right permeability, bioactivity and mechanical properties to seed, grow and mechanically 
stimulate primary cells in a reproducible manner (109). 
 
2.5. Future Challenges and strategy 
As already stated, robust spatial and temporal control of biophysical, biomechanical and 
biochemical micro-environmental cues through 3D biomaterial-based culture systems is 
essential for studying cell regulatory pathways and in vitro tissue regeneration. In this 
context, experimental models will have to increase progressively their complexity from basic 
to physiologically relevant structural and functional features (e.g dynamic and complex 
microenvironment of the native stem cell niche). A core challenge of this strategy will be to 
uncover the relationship between chemical (e.g. degradation), physical (e.g. microporosity) 
and mechanical (e.g. stiffness) scaffold properties, and cell signaling (32). This implies the 
accurate control and characterization of architectural, mechanical and physico-chemical 
biomaterial features, at micro- and macroscales, from synthesis, through shaping, until the 
sterilization steps. Unfortunately, physico-chemical properties (for review (104)) as well as 
architectural features (58) of scaffolds are still too often considered as non-significant 
parameters and thus become confounding variables; as evidenced by Kumar et al. speaking 
about the “unexpected sensitivity that cells have for scaffold structure” (67). In most cases, 
the whole scaffold manufacturing process (e.g. chemicals sourcing, phase synthesis, 
scaffolding method) is not enough accurate/standardized, and the final product not enough 
characterized to elucidate the link between scaffold features and biological response (38, 
110, 111). For instance in another study of Kumar et al., is the osteogenic differentiation of 
hBMSCs, seeded on etched poly(ε-caprolactone) scaffolds, induced by surface roughness or 
surface chemistry change (112) ? It is also unfortunate that series of studies on in vivo and in 
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vitro evaluation of silicon-substituted hydroxyapatite ceramics would have been published 
without any information about the real phase composition of the samples (110, 113), when 
it was recently shown that even small changes of silicon-substituted hydroxyapatite ceramic 
phase composition drastically modify cellular responses (114, 115). 
Defining the appropriate(s) composition(s) and the relevant architecture(s) of these new 3D 
systems for specific experimental goals remains a significant challenge (32). However, new 
design concepts and fabrication techniques currently available (e.g. additive manufacturing), 
even if they still display inherent feature limitations (81), provide alternatives for developing 
scaffolds with sufficient batch-to-batch similarity in geometrical, mechanical and physico-
chemical features to enhance our understanding of cell signaling (82, 83). To reach this goal 
both computational simulations and experimental studies are necessary, including extensive 
characterization of main scaffold features before and during in vitro tests in order to refine 
the numerical models. 
Therefore, we propose that, as an initial step, scaffold design should follow a simple -even 
simplistic- approach, comprising: 
(i) an isotropic macroporous architecture with continuous open pore geometry such as the 
one based on triply periodic minimal surfaces (TPMS) (50, 74). Compared to a random-pore 
architecture, this “basic” design could simplify both the identification of the variables 
affecting cellular response (by limiting assay variability and standardizing lab to lab assays), 
and the numerical simulations of the different physical variables which characterize the 3D 
biomaterial-based culture system (e.g. fluid flow profile experienced by cells). This 
architecture could also facilitate a dynamic monitoring of the cells by non-invasive imaging, 
for instance through confocal microscopy (50, 83). 
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(ii) a monophasic material with homogeneous and reproducible surface properties. The 
production of such material implies a perfect control of all production steps from chemical 
synthesis to sterilization. 
(iii) an accurate characterization of the actual chemical, physical, mechanical, architectural 
and biological properties of the manufactured scaffold by means of experimental techniques 
(e.g. µCT, spectroscopy, mechanical tests, osteoclast culture, degradation experiment), and 
computational methods (e.g. computer fluid dynamics simulation, finite element analysis). 
Since the properties of the scaffold are not only affected by cell activity, but also by culture 
conditions (e.g. mechanical stimulation, fluid flow, media composition), their evolution 
should be quantified in these conditions, i.e. without cell. 
 
3. CELL CULTURE 
3.1. Cell types and sources 
In bone biology, osteoblast-like cells are the most studied because they are easier to obtain, 
cultivate and use compared to osteoclast-like cells or osteocytes. For a comprehensive 
review focused on osteoclast-like cells or osteocytes, see (116) (these cells will not be 
discussed herein). Cells used for in vitro bone studies are either cell lines or primary cells 
isolated from human or animal tissue. In both cases, these cells display more or less 
differentiated features, ranging from stem-like cells to osteoblasts. Consequently, the choice 
of the cell type model (cell line or primary cells? Which cell lines? etc.) will depend on the 
goal of the study. 
A cell line is a homogeneous population of cells with the ability to proliferate in culture 
without limit, at least in theory, and therefore called “immortal” (117, 118). Cell lines are 
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obtained from cells isolated from bone tumors (cancer cell line) (119) or from primary bone 
cells which have undergone a spontaneous genetic change, such as p53 mutation (non-
transformed cell lines) (120). Primary cell can also be genetically/artificially modified to be 
"immortalised", they are then named “transformed cell lines” (121). The advantage of cell 
lines is the immediate availability of a large numbers of cells without the need for isolation, 
the ease of maintenance and the homogeneity of the cell cultures. Cell lines are less prone 
to the phenotypic variability observed in primary cell cultures, but at the cost of some 
functional characteristics that are lost after immortalisation. Thus, cell lines may not express 
all tissue-specific characteristics. 
For example, the non-transformed murine preosteoblasts MC3T3-E1 cell line (122) is 
commonly used for its high capacity of differentiation in response to materials (apatite), with 
or without differentiation medium (123). However, cultures of these cells have been shown 
to not mineralize as hydroxyapatite but in spots of a mineral of unknown form (124). Human 
osteosarcoma cell lines, such as MG-63 and SaOS-2, particularly useful in the study of 
interactions between osteoblasts and materials (125), as well as assessment of 
biocompatibility and osteoblast differentiation potential (126, 127), must also be used with 
caution. Indeed, the response obtained with these lines may differ from those obtained from 
healthy cells. As a case in point, Anselme team compared the deformation of the cell nuclei 
in response to substrate surface topography in “healthy” (HOP), cancerous (from 
osteosarcoma: OHS4, U2OS) and immortalised (F/STRO-1+A and FHSO6) (bone-forming) cells 
(128). Cancer cells displayed a strong deformation, immortalised cells showed reduced 
deformation, while healthy cells were deformed only after short incubation times. Along 
with other results (129, 130), this study highlights the impact of immortalization on the 
state/responsiveness of the cytoskeletal network, leading to a modified behaviour compare 
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to healthy cells (128). Overall (see also (116, 131)), cell lines are useful for specific studies 
such as cytocompatibility testing or various stages of osteogenesis investigation, but do not 
reflect the behaviour of primary cells. Additionally, many cell lines can become unstable with 
time, and subclones of these cell lines tend to develop in different laboratories, which can 
lead to different experimental outcomes and results no longer comparable between studies 
and/or laboratories.  
Primary cells provide an alternative to cell lines. They are “unadulterated/healthy” cells, 
cultivated directly from human or animal tissue. Populations of bone primary cells contain 
stem cells and osteoprogenitors (i.e. committed but undifferentiated cells). An evident 
advantage of primary cells is that they can be isolated from genetically modified animals in 
which the expression of a gene has been cancelled, forced or rendered conditional, as for 
instance BSP-/- mice used in our laboratory (132, 133). This avoids the direct manipulation of 
gene expression in the culture (e.g. RNA silencing), for which the transfection of the agent, 
as well as the efficiency and duration of its action are difficult to control.  
Many methods are available for the isolation of primary cells from bone. A common one is to 
digest small pieces of bone explants from long bone, calvaria (from rodent fetus or neonate), 
mandible or iliac crest with collagenase or other matrix-digesting enzymes (134, 135). 
Primary cells are also regularly isolated from the bone marrow (136).  
Bone marrow in adults harbours several types of stem and progenitor cells, hematopoietic 
(HSC) and non-hematopoietic, the latter including mesenchymal stem cells (MSC). MSC are 
undifferentiated cells with high proliferation capacity, able to self-renew and differentiate 
into different cell lineages, generating all mesenchymal tissues, such as bone, cartilage, 
tendons, muscles and fat (137). In vitro differentiation studies demonstrated the ability to 
isolate and multiply MSC from cartilage, trabecular bone, periosteum, adipose tissue and 
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periodontal ligaments (138-142). However, gene and protein profiles characteristic of these 
cells are still unclear. Recently, the European Genostem consortium elucidated the biology of 
stem cells from bone marrow, establishing that the native cells are localised on the 
abluminal side of endothelial cells of sinuses (143). They showed that stromal cells forming 
the niche of HSC and bone marrow MSC are the same entities, and that highly proliferating 
clonal cells, amplified in culture, are "true" stem cells since they display self-renewal and 
multipotency, similar to HSC (143). However, many questions remain unresolved. It is not 
clear, for instance, whether the self-renewal capacity of MSC is comparable to that of HSC 
(143). Thus, several important players in this field consider that the only true test of 
stemness is in vivo tissue/organ reconstitution from one single MSC, and they contest the 
notion of a universal MSC as opposed to tissue-specific (e.g. in the bone marrow, skeletal) 
stem cells (144). 
Anyway, the main practical disadvantage of the use of primary cells is that considerable 
variation may exist between cells of different tissue sources. Cell populations derived from a 
single tissue source may also be heterogeneous due to variations in the isolation and/or 
purification technique, or according to passage numbers. For instance, significant changes in 
contractile force were reported for chondrocyte after only three passages (145). In addition, 
primary cells are extremely sensitive to the batch of serum used (146-148), emphasizing the 
importance of the culture medium composition. The addition of certain factors, such as 
dexamethasone, ascorbic acid and β-glycerophosphate allows to direct these cells towards 
the osteoblastic differentiation pathway. Similarly, other inducing media exists to drive 
differentiation to adipocytes or chondrocytes. Also, in order to improve the homogeneity of 
marrow-derived populations, it is possible to sort and select cells with antibodies targeting 
cell type-specific membrane markers (149). 
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3.2. Complex 3D models: cell co-culture 
Tissue engineering mainly uses "minimalist" approaches using a single cell type. In contrast 
in vivo, the dynamics of the bone tissue – in particular, its remodelling - is based on an 
intimate cross-talk between different cell types: endothelial cells, matrix-embedded 
osteocytes, bone lining cells and more particularly osteoblasts and osteoclasts (150). 
In vitro osteoclast/osteoblast co-cultures on scaffolds allow the study of the remodeling 
process and, in particular, the crosstalk between resident osteoblasts and invading, 
differentiating, and resorbing osteoclasts. Tortelli et al. (151) developed a 3D model of bone 
by seeding primary murine osteoblasts and osteoclast precursors in a ceramic porous 
scaffold (placed in multiwell plate). Using this model, the team demonstrated through 
comparative analysis of transcriptional activities that the 3D environment stimulates 
osteoblast differentiation which, in turn, induces early differentiation of osteoclasts. Vacanti 
team also highlighted, in an osteoblast and osteoclast co-culture experiment, the formation 
of osteoclasts on polymer surfaces previously mineralized by osteoblasts Nakagawa (152). 
Osteoblasts and osteoclasts are not the only critical cells for bone remodeling. For a very 
long time, osteocytes have been ignored because it was assumed that they functioned as 
place holders in the bone matrix and that all the action took place on the bone surface. 
However, within the last decade these cells have been shown to act as orchestrators of bone 
remodeling (153, 154). More precisely, several experiments using conditioned medium (i.e. 
supernatant containing soluble factors from osteocytes) (155, 156) or different co-culture 
methodologies (155, 157, 158), in 2D substrate or in 3D gels (158, 159), support the concept 
that osteocytes regulate the function of both osteoblasts and osteoclasts. Moreover, 
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considerable convincing data emphasize the role of osteocytes as mechanosensors, 
integrating mechanical signals to regulate bone mass (153). Indeed, in experiments 
mechanically using parallel plate flow chambers, mechanically stimulated osteocytes inhibit 
osteoclastogenesis (160) and increase osteoblastic activity (laminar flow model, (161)). 
In vivo, angiogenesis and osteogenesis are closely linked and stringently regulated. Thus, 
interactions between osteoblasts and endothelial cells have been extensively studied. 
Complex cellular crosstalk between these cells have been reported in several in vitro studies 
(162, 163) using different co-culture models. Grellier et al. (164) made an inventory of these 
models, from the nature of the 2D and 3D substrates (e.g. spheroid or porous scaffolds with 
different compositions), to the cellular models used (e.g. rat long bone-derived osteoblast-
like cells, human umbilical vein endothelial cells or human bone marrow stromal cells) and 
the crosstalk between these different lineages. Co-culture of either osteoblasts or 
osteoprogenitor cells with vascular cells led to opposing conclusions about the ability of 
endothelial cells to induce or inhibit the expression of osteogenic genes (165). Indeed, such 
interactions depend on the origin and differentiation state of the two cell types, as well as 
the co-culture system used (2D or 3D substrates). However, when endothelial cells had an 
inducing effect, the in vitro concomitant mineralization of deposited matrix and formation of 
blood vessels have not been observed. Thus, there is much more to learn about the chemical 
and physical signals that drive the coordination of angiogenesis and osteogenesis in vitro. 
Recently, Papadimitropoulos et al. (166) developed a more complex in vitro model to mimic 
bone turnover by co-culturing osteoblasts, osteoclast and endothelial cells. To address the 
issue of the very short life of osteoclast cells, the authors developed a culture process in two 
steps. First, cells from the stromal-vascular fraction of adipose tissue, containing both 
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osteoprogenitors and endothelial lineage cells, were seeded then cultivated for a week in a 
perfusion bioreactor. In the second phase, CD14+ human peripheral blood cells were infused 
into the scaffold via the perfusion system. Non-invasive monitoring techniques (e.g. analysis 
of typical markers of bone remodeling in the culture medium) were used to quantify the 
bone matrix deposition and resorption processes, as well as to document the functional 
regulation of the system via osteoclastogenic and osteotropic factors (166). Unfortunately, 
these results do not allow to fully characterize the “quality” of the bone-tissue like formed 
(167). Bone quality encompasses several parameters such as bone remodeling level, matrix 
composition, bone mineralization degree, matrix and mineral composition. Monitoring of all 
these parameters are still missing in in vitro studies, which therefore do not established that 
the “bone-tissue like” material formed in the culture is comparable to “genuine bone”.  
Nonetheless, all co-culture studies, regardless the cell types used are useful to better 
understand the crosstalks regulating bone physiology. Most try to come closer to the 
physiological environment of the cells by using 3D matrices or mechanical stimulation. 
However, no study combines these two important conditions of the cell environment. It is 
thus a major issue to co-cultivate cells in 3D models allowing different type of mechanical 
stimulations. 
3.3. Cell seeding 
The cellular seeding of a porous scaffold is an important step in the setting up of a 3D 
culture. First, the initial seeding density impacts tissue formation. High cell densities are 
associated with stimulation of osteogenesis and increased bone mineralisation (168). 
Classically, a 30 mm3 macroporous biomaterial is inoculated with one million cells (169, 170). 
Second, the seeding protocol also affects the viability and distribution of cells within the 
scaffold, impacting the subsequent distribution of the tissue formed (171). Uniform cell 
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seeding is thus necessary to get uniform cell response within the scaffold and reproducible 
3D cell culture. 
3D cell seeding is generally performed under static conditions by placing a suspension of 
cells on top of the scaffold, which will penetrate within the material by capillary and gravity 
action. Although this standard method is widely used, it may result in low seeding efficiency 
and non-homogeneous distribution of cells in the scaffold (171-173). The seeding efficiency 
can be improved by placing the scaffolds in a stirred cell suspension. Spinner flask systems 
have been used for this purpose. However, the inefficient convection of the interior of the 
scaffolds can also lead to low cell densities  and non-homogeneous distribution of cells (171, 
174) with a higher density at the external surfaces (175). To further improve seeding 
efficiency, a flow of cells in suspension can be forced through the scaffold by means of a 
perfusion bioreactor. In this case, seeding and cell growth are successively performed 
without further manipulation, greatly reducing the risk of contamination. The use of 
perfusion bioreactor for cell seeding, developed in the next part of this review, allows a 
more homogeneous distribution of cells within the scaffold compared to static seeding or 
with spinner flask (171-173). However, the effective seeding conditions (e.g. seeding flow) 
have to be adjusted according to the type of perfusion bioreactor, the scaffold internal 
architecture, as well as the cell type(s) used. 
 
4. PERFUSION BIOREACTORS: the solution for in vitro 3D bone model(s) 
Nowadays, it is well established that a perfusion-based bioreactor is the most efficient 
culture system to homogenise nutrient transport, waste elimination as well as cell 
distribution, growth and differentiation in the interior of the scaffold (4, 176). These systems 
consist in forcing the culture medium through the cell-seeded scaffold. They are usually 
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composed of a scaffold chamber with a reservoir and a pump, all connected by tubing (Fig. 2 
A). Many perfusion bioreactors have been designed according to the goal of the study, using 
various scaffolds, cell types and perfusion modalities (i.e. mode and rate of fluid flow). These 
systems have been detailed in several interesting reviews (4, 5, 177). In addition to control 
and monitor many culture parameters throughout the tissue growth in vitro (e.g. pH, 
temperature, pressure, nutrient supply, waste elimination), perfusion bioreactors allow to 
study the role of mechanical cues on cell fate. Indeed, the perfusion and/or loading systems 
combined with the bioreactor can be used to mechanically stimulate the cells. 
 
4.1. The media: controlling and monitoring 
In order to live, a cell needs nutrients such as glucose, oxygen, amino acids, fatty acids, 
vitamins as well as specific factors. Among them, oxygen is much more than a required 
nutrient, it can act as signalling molecule to affect cell behaviour in several ways (178). Thus, 
high oxygen concentrations appear toxic to many cells, while low levels of oxygen can 
promote cell viability (179) and the differentiation of stem cells in vitro and in vivo (180-183). 
Moreover, while it is clear that the local oxygen pressure is a potent regulator of metabolism 
and viability of bone cells, the distribution profile of oxygen in bone is currently unknown. 
Nonetheless, mathematical models suggest that significant oxygen gradients exist between 
the cortical and cancellous bone, and that the partial pressure of oxygen (PaO2) can regulate 
the physical dimensions of trabeculae and osteons (184). Moreover, it is known that in vivo, 
the PaO2 is 5% in peripheral tissues, 6–7% in bone marrow and 1% in the endosteal niche 
(183). It should be noted that these values are low compared to the 21% PaO2 usually used 
in classical (2D) cell culture conditions. Apart from oxygen, a recent study showed that 
glucose concentration is an important factor in maintaining the viability and growth of MSC 
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in vitro (185). Deschepper et al. showed that MSC could sustain near-anoxia conditions only 
in the presence of glucose in vitro and in vivo (186).  
Thus, culture conditions and especially the chemical composition and homogeneity of the 
medium influence cell viability and behaviour. In static conditions, pure diffusive transport 
ensures oxygen and nutrients supply to the interior of the scaffold only to a distance of 
about 100 μm from the scaffold outer surface (187), similar to a 2D culture. In these 
conditions, cells are subjected to different oxygen and nutrient concentrations across the 
scaffold, leading to the formation by the outer cell layer of a tissue capsule in the periphery 
of the scaffold, further limiting penetration of culture medium inside the construct (176, 
188). More generally, the composition of the culture medium, including the availability of 
nutrients and the removal of waste products (e.g CO2, lactic acid, ammonia and products 
generated by oxidative stress), as well as the rate of exchange between the bulk medium 
and the construct interior are key parameters for 3D cell culture in vitro (4). Both parameters 
depend on the scaffold mass transfer properties (internal pore architecture discussed in 
section 2.3) and the culturing schemes (e.g. static vs perfused). As stated in introduction to 
this section, the perfusion bioreactor systems are currently unrivalled in terms of 
performance (e.g. cells activity and uniformity within the interior of the scaffold (176, 189, 
190). On the condition that the flow goes entirely through the scaffold and not around the 
edges, these systems allows an accurate control of the perfusion modalities of seeded cells 
(e.g. constant vs pulsatile) as well as their mechanical stimulation (see section 4.2), with the 
final aim to modulate stem cell fate (maintenance or differentiation) (4, 178).  
Finally, another advantage of perfusion bioreactor is the monitoring of crucial parameters 
like oxygen using invasive (embedded) or non-invasive (non-contact) sensing probes (191). 
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These monitoring tools/probes can also be used to follow the bone remodelling process as 
performed by Papadimitropoulos et al (see section 3.2) (166). 
 
4.2. Control of the mechanical stresses 
4.2.1. Mechanical bone environment 
In vivo, it is well known that bone remodelling is induced and controlled by endogenous and 
exogenous factors (192-194). Dynamic mechanical stresses are osteogenic within a range of 
load intensities; beyond and below this range tissue responses are different (195, 196).  
In weight bearing bone, individual cells are not subjected to a single force. Multiple physical 
signals are generated simultaneously and sensed/integrated by the cells through their 
membrane, cytoskeleton, focal points, etc. (Fig. 3). Consequently, there is no single 
parameter in the mechanical environment that reliably predicts bone remodelling in vivo or 
under experimental conditions (197). 
It is assumed that in vivo mechanical stimuli are mainly transmitted to bone cells through 
shear stress, that is to say forces whose vector is parallel to the cell surface (198). Bone 
tissue includes a significant fraction of interstitial fluid surrounding all cells. Movements of 
this fluid are induced by two different processes: an "internal" one, which is the differential 
pressure within the circulatory system (199, 200), and an "external" one consisting in the 
mechanical loads applied to the skeleton (201). Whenever a mechanical load is applied to 
bone, interstitial fluid is forced out of the areas of high compressive deformation, and flows 
back when the load is removed. Thus, the fluid flow generates an oscillating shear stress to 
which individual bone cells, and more especially the osteocytes, are sensitive (154).  
The different forces exerted on cells are integrated via several extracellular mechanosensor 
like integrins and associated proteins (203), ion channels (204), connexin (205), primary cilia 
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(206) and the actin cytoskeleton (207). These sensors take part in a set of cellular 
mechanisms that convert mechanical stimuli into biochemical signals (208) leading in 
changes of whole tissue metabolism (Fig. 3).  
In 3D models, many mechanical stresses can be generated and studied such as tension, 
torsion and different combinations of these. In fundamental bone in vitro models, two types 
of mechanical stresses are mostly studied: loading stress resulting from mechanical 
solicitation, and shear stress imposed by fluid movement from the perfusion and/or the 
scaffold deformation (27). 
Anyway, the control of these stresses is crucial to understand the transduction of mechanical 
signals by the bone cells or guide their fate. 
 
4.2.2. Fluid flow effects  
a) Shear stress in perfusion bioreactor  
In addition to overcoming poor nutrient and waste exchange associated with static culture 
conditions (188, 209), culture in a flow perfusion bioreactor provides a convenient way to 
mechanically stimulate cells seeded in the scaffold through fluid shear stress (198, 210). 
Indeed, it was proved in numerous 2D in vitro studies that cells involved in bone tissue 
remodeling are sensitive to shear stress (211-213). In scaffolds, fluid flow (shear stress) has 
been also shown to enhance bone formation activity of osteoblasts (214-216) and stimulate 
the expression of bone-specific genes (217). An unidirectional steady flow, commonly used 
in clinical studies (214, 215, 218), has been shown to have many biological effects on bone 
marrow stromal cells seeded in scaffolds, such as an enhancement of osteogenic 
differentiation (219) and an increased production of mineralized matrix (214, 220). However, 
since bone cells are mainly stimulated in vivo via dynamic (intermittent) mechanical loading 
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(221, 222), this dynamic regime is likely to be crucial for stimulating bone formation and 
enhancing the quality of bone tissue laid by osteoblast (223). Other studies revealed a 
favorable effect on bone tissue formation of dynamic unidirectional flow (224) or oscillatory 
fluid flow (170, 225). Lastly, a recent study showed that sequential application of steady (for 
2 weeks) and dynamic (for 3 weeks) fluid flow promotes bone formation by human adipose 
stem cells isolated from fat tissue and cultivated on porous silk fibroin scaffolds (226). 
These results suggest that there is a cellular mechanism detecting and responding to the 
level and duration of shear stress induced by fluid flow. The level of shear stress experienced 
by cells cultured in a flow perfusion system varies with the flow rate. The local shear stress 
felt by individual cells will thus depend on the flow rate used throughout the perfusion-
seeding (172, 227), as well as the scaffold architecture (see section 2.3). It remains unclear 
which flow profile is optimal for stimulating osteoblasts cultivated in a scaffold, and how it 
will regulates their activity and sensitivity. Such evaluation can be done using predictive tools 
(computational fluid dynamics technology (228, 229)).  
 
b) Biologically relevant shear stress  
Most culture systems and bioreactors are not yet optimized on a mechanical point of view 
(mechanical stimuli generation). In the design of the perfusion bioreactors (3D in vitro 
studies), parameters, such as rate of perfusion, flow design (unidirectional, oscillatory, 
intermittent, etc.) and scaffold architecture have often been determined through trial-and-
error (54, 230). Such empirical methods do not guarantee that these parameters are 
optimized. But computational tools are now available to determine the optimal values of 
these parameters. In order to improve the mechanostimulation of cells in bioreactors, it is 
 30
first necessary to determine which levels of shear stress are relevant, and secondly to be 
able to evaluate the shear stress levels on scaffolds surfaces. 
• Effective levels of shear stress in 2D cultures 
It is relevant to wonder about the levels of shear stress that provide the best stimulation in 
bone cell function. A first value of reference was given by Weinbaum et al. in 1994 (231) 
through a model based on Biot's porous media theory, which is used to relate the loads 
applied to bone to the flow of canalicular interstitial fluid. The model predicts that the flow 
of physiological fluid induces shear stresses in the range of 0.8 to 3 Pa when bones are 
submitted to physiological loadings. 
Many research teams analyzed experimentally the effect of shear stress on bone cell activity. 
To control the shear stress applied, parallel-plate flow chambers were developed and used in 
vitro with several types of cells and several shear stress regimens (e.g. frequency, time). A 
selection of the most relevant results is presented in Table 1. In these 2D experiments, shear 
stress levels between 0.1 and 2 Pa caused positive effects on cells such as release of nitric 
oxide and PGE2, phosphorylation of proteins ERK1/2 and p38, as well as up-regulation of the 
expression of some genes related to mechanotransduction and osteoblastic differentiation. 
• Levels of shear stress in 3D, numerical simulation and confrontation with 2D values 
Scaffolds used for bone tissue engineering applications provide, by definition, a 3D structure 
with generally complex geometries. It is then impossible to control and homogenise the 
levels of shear stress experienced by cells in such structure. But some numerical methods 
were developed to evaluate these levels. Nowadays, numerical simulation is very widely 
used by researchers to simulate mechanical and/or biological environment experienced by 
cells seeded in scaffolds, to become a crucial research field. For an extensive review of 
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current simulation techniques and strategies for dynamic bone tissue engineering in 
bioreactors we recommend a recent review by Vetsch et al. (239). Several research teams 
investigated the levels of flow-induced shear stress in their own system (i.e. bioreactor and 
scaffold (240-242)). A first step of modeling is generally achieved by analyzing the scaffold 
through micro-computed tomography in order to reconstruct its 3D architecture 
numerically. The reconstructed geometry of the scaffold can then be implemented in 
numerical simulations. Computational fluid dynamics methods for fluid simulation are used, 
such as Lattice Boltzmann (240, 243), finite volume (70, 241, 244) or finite element methods 
(71, 245, 246). Boundary conditions are implemented to reproduce the real fluid circulation. 
Then, calculation enables to determine the fluid velocity and the wall shear stress in the 
scaffolds. The shear stress levels calculated under certain hypotheses are listed in Table 2. 
We would like to emphasize that due to the highly randomized internal pore structure of the 
scaffolds used for these experiments, the shear stress distribution is very heterogeneous and 
we should retain the order of magnitude rather than the values themselves. It is very 
interesting to note that the calculated shear stress levels are in the range of 0.04 to 40 mPa 
with boundary conditions of the numerical models representing the experimental 
conditions. These values are two to three orders of magnitude lower than the values 
reported in the 2D experimental studies (Table 1). This gap has been reported and explained 
in several works (247, 248). When cells are seeded in highly porous scaffolds, approximately 
75% of them display a “bridging” morphology (i.e. they are suspended cells, as observed in 
Fig. 1 C), in contrast to the “flat” 2D morphology (i.e. in which cells lay flat on the substrate) 
(247). Even if this proportion could vary depending on internal pore architecture and cell 
type, these “bridging” cells exist and experience high levels of deformation compared to the 
“flat” cells; up to 500 times higher for the same flow configuration. This is very probably why 
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the osteogenic responses can be observed at lower levels of wall shear stress in scaffold 
structures containing mainly bridging cells than in 2D culture experiments or in other types 
of bioreactors where cells are mainly flatly attached. 
 
4.2.3. Effects of mechanical loading 
While shear stress has been extensively used to mechanically stimulate cells in 3D, little has 
been done on cell response induced by compression forces in vitro.  
Specially designed culture chambers are necessary to apply external mechanical signals 
combining shear and loading stresses (64, 109, 249, 250) (Fig. 2 A). This type of chamber 
makes possible to mimic in vitro the skeletal effects of physical activity. Mechanical loads 
generate substrate deformations inducing in parallel fluid flow shear stress (media 
movement within the scaffold). Both are more or less intense depending on the properties 
of the scaffold (see section 2). These deformations are experienced by the cells, through the 
ECM or directly through changes in cell shape or intercellular distances. Substrate elongation 
or compression can directly modify extracellular gradients, cell-cell communication or local 
concentrations of secreted ligands (251).  
Globally, bioreactor systems designed for applying mechanical loading have shown beneficial 
effects of mechanical load on proliferation, osteogenic differentiation and matrix formation 
(Table 3). Specifically, it has been shown that compressive strains of approximately 10% 
(amounting to a stress of about 12 kPa) are osteogenic (Table 3). Other bioreactors 
(prototypes) have been designed and technically validated but have not been yet used in 
routine for biological evaluations (255, 256). Some of the bioreactors listed in Table 3 are 
not perfused. This technical restriction limits their experimental applications due first to the 
negative points inherent in the nature of the unperfused systems and especially static 
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cultures (see section 4.1), and second to the impossibility to combine the effects of both 
compression and perfusion. 
Lastly, all these studies are currently done with osteoblast-like cells in order to determine 
the effect of mechanical forces on bone formation. The next step will be to study their 
effects on bone resorption using (pre)osteoclasts with the ultimate goal to co-cultivate 
either or both cell types with the bone mechanosensor, the osteocyte. 
 
5. PERSPECTIVES IN 3D IMAGING 
As the field of 3D tissue engineering progresses there is a growing need for non-invasive, 
label-free imaging technologies for detailed analysis of the inside of the scaffolds, with high 
resolution and real-time observation capabilities throughout the culture period. Two on-line 
imaging systems able to monitor the 3D morphological structure of the mineralized and 
unmineralized fractions of the cultures will be presented: Optical Coherence Tomography 
(OCT) and the micro/nano tomography.  
Operating under a principle similar to ultrasound imaging, with the exception that it 
measures delays in backscattered light instead of sound, OCT uses light in the near infrared 
part of the spectrum. OCT yields 3D tomographic images of biological tissues with a 
resolution of a few micrometres. This non-invasive, non-ionising method has been recently 
used for imaging a fixed human femoral trabecular bone sample (257). Without any staining, 
the lamellar structure of trabeculae and the cells in the marrow were visible, albeit with a 
penetration depth limited approximately to 1 mm (258, 259). To improve the capabilities of 
OCT several extensions have been proposed including polarization, phase and spectrally 
resolved OCT. Spectroscopic Optical Coherence Tomography (SOCT) is sensitive to both 
chromophores and structural changes of the tissue, which alter the incident light spectrum. 
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The performance of such approach has been tested for contrast enhancement in bovine 
osteo-articular cartilage. Specifically, when the tissue is loaded the different layers of 
cartilage get enhanced contrast due to optical clearing. During cartilage compression, water 
is expelled out of the tissue and the change of the collagen fibre composition in the different 
zones could be a reasonable explanation for the enhanced contrast due to spectroscopic 
features (260). Whether some interesting results on structural investigation of native bone 
have been gathered, the applications of these techniques to in vitro tissue-engineered bone 
are not yet very numerous at present (260). 
Micro-computed tomography (micro-CT) is often used to characterise scaffolds and bone 
growth in 3D (261). Micro-CT uses X-rays and provides a non-destructive 3D image of the 
interior of a sample, regardless of size, with a resolution ranging from 1 to 100 μm. The 
combination of micro-CT and recently developed microdiffraction,  x-ray techniques have 
facilitated qualitative and quantitative characterisation of dense scaffolds, as well as a 3D 
evaluation of the rate of bone growth in engineered tissue (262). More specifically X-ray 
microdiffraction provides information at the atomic scale, i.e. at the nanometre level, of 
both mineral and organic phases. Wide angle X-ray scattering (WAXS) informs mainly about 
the crystallographic structure and texture of the samples, while Small angle X-ray scattering 
(SAXS) is more about size, shape and orientation of both the mineral crystals and collagen 
fibrils (262) which compose the sample. Synchrotron radiation tomography (SRT) has 
enabled acquisition of even better results in terms of spatial resolution (under 1 μm) and 
signal/noise ratio (263). In addition to revealing the architecture of the sample, SRT also 
provides information about composition (i.e. the 3D distribution and degree of 
mineralisation) (264). However, equipment to perform this technique is only available in a 
few research centres around the world.  
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Micro-CT and SRT techniques allow visualisation and quantification of mineralised 
structures, including the possibility to investigate the influence of scaffold features, such as 
the internal pore architecture (e.g. size, distribution) with regard to the growth of bone 
within the scaffold. Unfortunately, this method does not yet allow to visualise the cells. "X-
ray synchrotron radiation pseudo-holotomography" was recently developed to visualise soft 
tissue and microvascular networks in 3D without the use of contrasting agents. The method 
is based on micro-CT and conventional holotomography techniques and was used to obtain 
quantitative structural data on a bioceramic/MSC composite implanted in mice for 24 weeks 
(265).  
If major improvements in mapping and monitoring 3D tissue growth have been achieved, 
progress is still required in quantifying changes in depth with the appropriate resolution for 
cellular analysis. Further bioreactor should be designed to allow for in situ imaging with the 
help of optical and/or x-ray transparent culture chambers or by placing transparent windows 
on the chamber walls.   
 
6. CONCLUSIONS 
Traditional cell culture, i.e. two-dimensional (2D), is unable to reproduce the tissue 
properties observed in organs (3D). Moreover, natural tissues, especially in weight-bearing 
organs such as bone, are subjected to mechanical stresses which are major regulating factors 
for cell fate. In vitro 3D culture models seem to be an effective solution to better understand 
the different aspects of cell function and bone remodeling in systems less complex than in 
vivo models. Create bone in vitro, using tissue engineering concepts, can be a somewhat 
elusive vision given the complexity of this tissue, encompassing spatial and temporal 
interactions between many types of components (e.g. cells, ECM, substrate, soluble factors). 
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However, new experimental, manufacturing, characterization and computational tools help 
to design a controlled environment more and more efficient to regulate cell fate. Even, if the 
influence of material properties, such as stiffness, permeability, or composition, in orchestrating 
cellular events is still poorly understood, the “design strategy” associated to an extensive scaffold 
characterization is a consistent approach to define relevant scaffold design/features. Perfusion 
based bioreactors have been shown to optimize cell culture in 3D with full and standardized 
control of cell environment (e.g. scaffold architecture and physico-chemical properties, 
medium composition and delivery, mechanical stimuli) (Fig. 4). This new way to cultivate 
cells requires a redefinition of standard cell culture methods applied in two dimensions (2D) 
starting with cell seeding techniques and growth conditions (e.g. O2 levels). The development 
and follow-up of such controlled and constrained systems also calls for a multidisciplinary 
knowledge, relying on close collaboration between researchers and engineers specialising in 
biology (molecular and cellular), chemistry, physics and mechanics (of solid and fluid 
matter).  
Development of advanced methods for real-time analysis is required to characterize and 
monitor the physical and chemical environment of the cells and their interactions with the 
construct. No 3D in vitro culture strategy can provide a "complete" model of bone tissue (i.e. 
its different components). For this reason, rather than attempting to build the perfect 
general 3D bone model, research should focus on developing specific tools for the purpose 
of solving one or several well thought biological questions. To conclude, this approach will 
serve basic research, provide a test bench for the development of active molecules targeting 
bone cell as well as therapeutic applications (implantations). The trial-and-error approach 
mostly used to validate scaffold/biomaterial properties for implantation (e.g. composition, 
 37
architecture) or implant manufacturing (e.g. rhBMP2 dose, preculture in bioreactor before 
implantation) could be guided by results obtained in these in vitro 3D culture systems. 
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Tables 
Table 1: Effects of shear stresses on bone cells seeded on glass in parallel plate flow 
chambers 
 
References Cell types 
Shear 
stress level 
Shear stress regimen Observations 
Bakker, 2001 
(232) 
Mouse primary cells from 
adult long bone 
0.4 Pa, 0.6 
Pa and 1.2 
Pa 
Pulsating ﬂuid ﬂow, 
3Hz, 5Hz or 9 Hz, 
15min 
 
NO and PGE2 production 
Alford, 2003 
(233) 
Mouse osteocyte-like cell 
line, MLOY-4 
 
1 Pa Oscillating ﬂuid ﬂow, 
1Hz, 1h 
Phosphorylation of Cx43 
Up-regulation of GJIC 
Kapur, 2003 
(234) 
Human primary 
osteoblasts from mandible 
bone chips 
2 Pa Steady fluid flow, 
30min 
Increase of [
3
H]thymidine incorporation, ALP 
activity, phosphorylation of ERK and expression 
of integrin β1 
 
Bacabac, 2004 
(235) 
Mouse pre-osteoblast cell 
line, MC3T3-E1 
0.7 Pa Steady and pulsating 
fluid flow, 5 or 9Hz, 
15min 
 
NO production (NO2
-
 accumulated in the 
conditionel medium) 
Knippenberg, 
2005 
(236) 
Goat primary 
mesenchymal stem cells 
from adipose tissue 
 
0.6 Pa Pulsating fluid flow, 
5Hz, 1h 
Increase of NO production and upregulation of 
Cox2 gene expression 
Kreke, 2005 
(237) 
Rat primary bone marrow 
stromal cell culture 
0.16 Pa Steady fluid flow, 
5min, 30min or 
120min 
Increase of ALP activity, increase of the 
expression of osteopontin and bone sialoprotein 
mRNA, increase of PGE2 
 
Mullender, 
2006 
(238) 
Mouse pre-osteoblast cell 
line, MC3T3-E1 
0.18 and 
0.64 Pa 
Steady and pulsating 
fluid flow, 1Hz, 5Hz or 
9Hz, 15min 
 
NO and PGE2 production increased 
Kreke, 2008 
(211) 
Rat primary bone marrow 
stromal cell culture 
0.23 Pa Continuous and 
intermittent (5min 
on/5min off) fluid 
flow, 24h 
 
Increase of the phosphorylation of ERK and p38 
Increase of PGE2 
Grellier, 2009 
(212) 
Human primary bone 
marrow stromal cell 
culture 
1.2 Pa Steady fluid flow, 
30min and 90min 
Gene expression : ALP increased, Cx43 increased, 
Col I decreased 
Phosphorylation of ERK1/2 and p38 
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Table 2: Numerical models prediction of shear stress values induced by flow within scaffolds 
References Scaffold Numerical method 
Calculated mean wall 
shear stress 
Porter, 2005 
(240) 
 
Human trabecular bone Lattice-Boltzmann 0.05 mPa 
Boschetti, 2006 
(245) 
Polylactic acid (PLLA) porous scaffold Finite element method 3.7mPa (« Reference 
model ») 
 
Cioffi, 2006 (241) Biodegradable polyestherurethane foam 
scaffold 
Finite volume method 3.94, 3.73, and 3.28 mPa vs 
model 
Cioffi, 2008 (70) Polyethylene glycol 
terephthalate/polybutylene 
terephthalate (PEGT/PBT) foam scaffold 
 
Finite volume method 2.56 and 0.256 mPa vs inlet 
flow 
Sandino, 2008  
(308) 
Porous and biodegradable scaffolds : 
caclium phosphate and glass 
 
Finite element method 0.05 mPa (Modal values) 
Milan, 2009 (71) PLLA-glass scaffold Finite element method Between 0.04mPa and 
40mPa vs inlet flow 
 
Melchels, 2011 
(50) 
2 PLLA scaffolds with gyroid pore 
architectures 
 
Finite volume method 31 and 27 mPa 
Yan 2011, (229) Chitosan-hydroxyapatite scaffolds with 
regular structure 
 
Finite element method Between 1 and 7 mPa 
VanGordon, 2011 
(243) 
PLLA porous foam scaffold and 
nonwoven fiber mesh scaffold 
Lattice-Boltzmann Between 12 mPa and 25 
mPa vs inlet flow and 
geometry 
 
Maes, 2012 (244) Titanium and hydroxyapatite scaffolds Finite volume method 1.41 and 1.09 mPa 
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Table 3: Direct mechanical loading of cells seeded scaffolds – Modalities and effects 
Bouet.Table3 
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Figures 
 
Figure 1. Images from micro-computed tomography (m-CT) and scanning electron 
microscopy (SEM) of CaP scaffolds manufactured through standard replication of PMMA 
(Polymethyl Methacrylate) template, (A) without micropore, with micropores (B) before and 
(C) after 7 days of culture in perfusion bioreactor with mouse calvarial cells (steady flow of 2 
µL/min); the yellow arrow on image B1 displays the interconnection pore magnified in image 
B2.  
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Figure 2. Models of bioreactors. (A) Example of perfusion bioreactor in which the culture 
medium is forced through the internal interconnected porous network of the seeded 
scaffold. This can override diffusion limitations and enhance nutrient delivery and waste 
removal from the cultured cells. The setup includes a medium reservoir, a pump and a 
tubing system which feeds the culture chamber; (B) Example of perfusion bioreactor 
allowing the application of controlled dynamic compression to the scaffolds perpendicularly 
to fluid flow in a dissociated or combined manner. 
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Figure 3. Actors and mechanisms of cellular mechanosensing. Mechanical forces can be 
sensed and transduced by different means through membrane and/or organelle 
deformation or cell/ECM interactions.  
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(A) At the cell membrane level, mechanosensitive ions channels and caveolae (not yet 
demonstrated in bone cell but in endothelial cells (202)) detect fluid flow or membrane 
stretching. Ion channels respond by gating, leading to the entry of ions inside cell (203) and 
caveolae by flattening and activation of specific signaling pathways. Moreover, bone cells 
possess a single microtubule-based primary cilium which projects from the cell surface and is 
deflected by fluid flow (206). Its membrane contains receptors and channels which 
participate in numerous signaling events and play an important role in the mediation of 
flow-induced calcium deposition by osteoblasts (206). 
(B) Mechanical stimulation leads to cell cytoskeletal deformation including actin (stress fiber) 
reorientation, microtubule polymerization/depolymerisation and intracellular protein 
displacement (concentration) permitting their interaction and effecting the signal 
transduction of the original force (207). 
(C) As the main cellular mechanical detection mechanism, the transmembrane receptors 
integrins bind to ECM proteins (e.g. collagen, fibronectin) and activate a mechanosensory 
protein complex (involving talin, vinculin and focal adhesion kinase (FAK) linked to a kinase 
cascade system (203). 
(D) Cell-cell adhesion, via tight (1) and adherens junctions (2) as well as desmosomes (3), 
precedes and controls intercellular communication via gap junctions (4), transcellular 
channels formed by the matching of connexin protein complexes between two neighboring 
cells. Gap junctions are involved in the propagation of intercellular calcium waves which 
activate mechanosensitive signal transduction pathways (205).  
(E) The multiple transduction signal pathways are integrated by the nucleus and induce 
changes in gene expression and protein production leading to cell behavior adaptation. 
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Figure 4. Schematic representation of the key elements of in vitro 3D culture model 
including: cell type choice depending on the goal of the study, main scaffold and bioreactor 
features needed, as well as characterization tools.  
Abbreviations: AA = ascorbic acid, βGP = β-glycerophosphate, ALP = alkaline phosphatase, 
CTX = carboxy-terminal collagen crosslinks, PINP = amino-terminal propeptide of type I 
collagen, OCT = optical coherence tomography, micro-CT = micro-computed tomography. 
 
 
 
 
 
